Smith Robin L
Transactions
50
Companies
11
Filings
13
CIK
0001365035
Recent Transactions
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Exercise/Conversion
- Exercise/Conversion
- Exercise/Conversion
- Exercise/Conversion
- Award
- Award
- Award
- Award
- Purchase
- Award
- Purchase
- Award
- Award
- Award
- Award
- Award
- Award
- Award
EMPLOYEE STOCK OPTION (right to purchase
2019-05-08+100,000→ 100,000 total - Award
- Award
- Award
EMPLOYEE STOCK OPTION (right to purchase)
2018-10-08+48,000→ 48,000 total - Award
- Award
- Award
- Award
- Award
Employee Stock Option (right to buy)
2018-04-16+150,000→ 150,000 total - Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
Companies
11- $CELU
Celularity Inc
Director
CONCENTRIX SREV, INC.
Director
- $CYCU
Cycurion, Inc.
Director
- $EMMA
Emmaus Life Sciences, Inc.
Director
- $LSTA
LISATA THERAPEUTICS, INC.
Director, CEO and Chairman of the Board
- $MTNB
Matinas BioPharma Holdings, Inc.
Director
PROLUNG INC
Director
- $RMTI
ROCKWELL MEDICAL, INC.
Director
SEELOS THERAPEUTICS, INC.
Director
Sorrento Therapeutics, Inc.
Director
- $VRDN
Viridian Therapeutics, Inc.\DE
Director
Recent Filings
13- 4
Smith Robin L
May 2, 2025
- 4
Smith Robin L
Jun 16, 2023
- 4
Smith Robin L
Aug 18, 2022
- 4
Smith Robin L
Jul 15, 2022
- 4
Smith Robin L
Sep 13, 2021
- 4
Smith Robin L
Sep 3, 2021
- 4
Smith Robin L
Aug 30, 2021
- 4
Smith Robin L
Jul 20, 2021
- 4
Smith Robin L
Jun 15, 2020
- 4
Smith Robin L
May 21, 2020
- 4
Smith Robin L
May 14, 2020
- 4
Smith Robin L
Mar 6, 2020
- 4
Smith Robin L
Mar 5, 2020
Address
C/O NEOSTEM, INC. 420 LEXINGTON AVENUE, SUITE 450
NEW YORK, NY, 10170